Is EPGNF or RYLD a better dividend investment in 2026?

EPGNF currently yields 178.57% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: EPGNF offers higher current income.

What is the dividend yield difference between EPGNF and RYLD?

EPGNF has a forward dividend yield of 178.57% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 166.43 percentage points.

Home › Compare › EPGNF vs RYLD

EPGNF vs RYLD: Dividend Comparison 2026

EPGNF yields 178.57% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EPGNF wins by $62.87M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EPGNF

● Live price

178.57%

Share price

$1.12

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$62.91M

Annual income

$29,936,192.20

Full EPGNF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — EPGNF vs RYLD

📍 EPGNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EPGNF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EPGNF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EPGNF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EPGNF

Annual income on $10K today (after 15% tax)

$15,178.57/yr

After 10yr DRIP, annual income (after tax)

$25,445,763.37/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, EPGNF beats the other by $25,443,564.12/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EPGNF + RYLD for your $10,000?

EPGNF: 50%RYLD: 50%

100% RYLD50/50100% EPGNF

Portfolio after 10yr

$31.48M

Annual income

$14,969,389.77/yr

Blended yield

47.55%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EPGNF buys

RYLD buys

No recent congressional trades found for EPGNF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEPGNFRYLD

Forward yield	178.57% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$62.91M ✓	$44.5K
Annual income after 10y	$29,936,192.20 ✓	$2,587.35
Total dividends collected	$58.90M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: EPGNF vs RYLD ($10,000, DRIP)

Year	EPGNF Portfolio	EPGNF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$28,557	$17,857.14	$11,914	$1,213.65	+$16.6K → EPGNF
2	$78,215	$47,658.78	$14,099	$1,351.30	+$64.1K → EPGNF
3	$205,683	$121,992.76	$16,580	$1,494.55	+$189.1K → EPGNF
4	$519,899	$299,818.53	$19,384	$1,642.61	+$500.5K → EPGNF
5	$1,264,557	$708,265.17	$22,535	$1,794.70	+$1.24M → EPGNF
6	$2,963,097	$1,610,021.03	$26,063	$1,950.00	+$2.94M → EPGNF
7	$6,696,294	$3,525,779.94	$29,995	$2,107.69	+$6.67M → EPGNF
8	$14,611,669	$7,446,634.50	$34,361	$2,266.99	+$14.58M → EPGNF
9	$30,820,422	$15,185,936.42	$39,194	$2,427.12	+$30.78M → EPGNF
10	$62,914,044	$29,936,192.20	$44,525	$2,587.35	+$62.87M → EPGNF

EPGNF vs RYLD: Complete Analysis 2026

EPGNF — Stock

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.

Full EPGNF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this EPGNF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EPGNF vs SCHD EPGNF vs JEPI EPGNF vs O EPGNF vs KO EPGNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.